Abstract | BACKGROUND: OBJECTIVES: METHODS: RESULTS: After two doses of IPV 96 to 100% of infants had antibodies to poliomyelitis viruses types 1, 2 and 3, and after a third dose of vaccine (IPV or OPV) all but one child had antibodies to all three poliovirus types. After two doses of COMVAX 89 and 96% of children had protective levels of antibody to Hib and hepatitis B, respectively. CONCLUSIONS: IPV is highly immunogenic in a two-dose schedule. Administration of a third dose of IPV or a dose of OPV at 6 months of age is highly effective. Simultaneous administration of a combination H. influenzae type b/ hepatitis B vaccine did not interfere with the response to IPV.
|
Authors | N A Halsey, M Blatter, G Bader, M L Thoms, F F Willingham, J C O'Donovan, L Pakula, F Berut, K S Reisinger, C Meschievitz |
Journal | The Pediatric infectious disease journal
(Pediatr Infect Dis J)
Vol. 16
Issue 7
Pg. 675-9
(Jul 1997)
ISSN: 0891-3668 [Print] United States |
PMID | 9239772
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Haemophilus Vaccines
- Haemophilus influenzae type b polysaccharide vaccine
- Hepatitis B Vaccines
- Poliovirus Vaccine, Inactivated
- Polysaccharides, Bacterial
- Vaccines, Inactivated
|
Topics |
- Bacterial Capsules
- Female
- Haemophilus Vaccines
(administration & dosage, adverse effects, immunology)
- Hepatitis B Vaccines
(administration & dosage, adverse effects, immunology)
- Humans
- Infant
- Male
- Poliovirus Vaccine, Inactivated
(administration & dosage, adverse effects, immunology)
- Polysaccharides, Bacterial
(administration & dosage, adverse effects, immunology)
- Vaccines, Inactivated
(administration & dosage, adverse effects, immunology)
|